Evidence map›Paper›PMID 34088983›Full record

ArticleCell death and differentiation2021

RNF20 and RNF40 regulate vitamin D receptor-dependent signaling in inflammatory bowel disease.

Robyn Laura Kosinsky, Maria Zerche, Ana Patricia Kutschat, Asha Nair, Zhenqing Ye, Dominik Saul, Maximilian von Heesen, Jessica J Friton, Ana Carolina Schwarzer, Nadia Paglilla and 8 more

Open access · hybridAbstract read
In one paragraph

Article in Cell death and differentiation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Decoding RNF20: an epigenetic modifier and beyond.Frontiers in cell and developmental biology · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Epigenetics of Inflammatory Bowel Diseases.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2023
    Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 2 countries.

Robyn Laura Kosinsky *Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA. kosinsky.robynlaura@mayo.edu.ORCID http://orcid.org/0000-0003-2869-7762
Maria Zerche *Department of General, Visceral and Pediatric Surgery, University Medical Center Goettingen, Goettingen, Germany.
Ana Patricia KutschatDepartment of General, Visceral and Pediatric Surgery, University Medical Center Goettingen, Goettingen, Germany.
Asha NairDivision of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.
Zhenqing YeDivision of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.
Dominik SaulKogod Center on Aging and Division of Endocrinology, Mayo Clinic, Rochester, MN, USA.
Maximilian von HeesenDepartment of General, Visceral and Pediatric Surgery, University Medical Center Goettingen, Goettingen, Germany.
Jessica J FritonDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
Ana Carolina SchwarzerDepartment of General, Visceral and Pediatric Surgery, University Medical Center Goettingen, Goettingen, Germany.
Nadia PaglillaDepartment of General, Visceral and Pediatric Surgery, University Medical Center Goettingen, Goettingen, Germany.
Shehzad Z SheikhCenter for Gastrointestinal Biology and Disease, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Florian WegwitzDepartment of General, Visceral and Pediatric Surgery, University Medical Center Goettingen, Goettingen, Germany.ORCID http://orcid.org/0000-0003-0750-6998
Zhifu SunDivision of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0001-8461-7523
Michael GhadimiDepartment of General, Visceral and Pediatric Surgery, University Medical Center Goettingen, Goettingen, Germany.
Rodney D NewberryDivision of Gastroenterology, Washington University School of Medicine, St. Louis, MO, USA.
R Balfour SartorCenter for Gastrointestinal Biology and Disease, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
William A FaubionDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
Steven A JohnsenDepartment of General, Visceral and Pediatric Surgery, University Medical Center Goettingen, Goettingen, Germany. johnsen.steven@mayo.edu.ORCID http://orcid.org/0000-0003-1198-5805
Mayo Clinic · USMayo Clinic in Arizona · USUniversity of North Carolina at Chapel Hill · USWashington University in St. Louis · US

Funding

PILOT AND FEASIBILTY PROGRAMP30DK084567 · NIDDK · MAYO CLINIC ROCHESTER · PI GREGORY J. GORES · 2009 to 2026
$22.2M
KLF10 regulates colitis through mediating TGFb induction of FOXP3 in Treg cells.R01AI089714 · NIAID · MAYO CLINIC ROCHESTER · PI FAUBION, WILLIAM A · 2011 to 2025
$6.3M
NIAID NIH HHS R01 AI089714NIDDK NIH HHS P30 DK084567
6 · The paper itself

Abstract

Despite the identification of several genetic factors linked to increased susceptibility to inflammatory bowel disease (IBD), underlying molecular mechanisms remain to be elucidated in detail. The ubiquitin ligases RNF20 and RNF40 mediate the monoubiquitination of histone H2B at lysine 120 (H2Bub1) and were shown to play context-dependent roles in the development of inflammation. Here, we aimed to examine the function of the RNF20/RNF40/H2Bub1 axis in intestinal inflammation in IBD patients and mouse models. For this purpose, intestinal sections from IBD patients were immunohistochemically stained for H2Bub1. Rnf20 or Rnf40 were conditionally deleted in the mouse intestine and mice were monitored for inflammation-associated symptoms. Using mRNA-seq and chromatin immunoprecipitation (ChIP)-seq, we analyzed underlying molecular pathways in primary intestinal epithelial cells (IECs) isolated from these animals and confirmed these findings in IBD resection specimens using ChIP-seq.The majority (80%) of IBD patients displayed a loss of H2Bub1 levels in inflamed areas and the intestine-specific deletion of Rnf20 or Rnf40 resulted in spontaneous colorectal inflammation in mice. Consistently, deletion of Rnf20 or Rnf40 promoted IBD-associated gene expression programs, including deregulation of various IBD risk genes in these animals. Further analysis of murine IECs revealed that H3K4me3 occupancy and transcription of the Vitamin D Receptor (Vdr) gene and VDR target genes is RNF20/40-dependent. Finally, these effects were confirmed in a subgroup of Crohn's disease patients which displayed epigenetic and expression changes in RNF20/40-dependent gene signatures. Our findings reveal that loss of H2B monoubiquitination promotes intestinal inflammation via decreased VDR activity thereby identifying RNF20 and RNF40 as critical regulators of IBD.

Indexed as

AnimalsCell Line, TumorCell ProliferationHumansInflammatory Bowel DiseasesMiceProtein Processing, Post-TranslationalReceptors, CalcitriolSignal TransductionUbiquitin-Protein LigasesReceptors, CalcitriolRNF20 protein, mouseRnf40 protein, mouseUbiquitin-Protein Ligases

Identifiers

PMID34088983
PMCPMC8563960
OpenAlexW3164771498

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.